These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 14557329)
1. Canadian media say DTC pharma ads the right Rx. Sibbald B CMAJ; 2003 Oct; 169(8):822. PubMed ID: 14557329 [No Abstract] [Full Text] [Related]
2. Can DTCA bring you patients? Newman BY J Am Optom Assoc; 1999 Sep; 70(9):561. PubMed ID: 10547970 [No Abstract] [Full Text] [Related]
3. Drug risks and free speech--can Congress ban consumer drug ads? Shuchman M N Engl J Med; 2007 May; 356(22):2236-9. PubMed ID: 17476002 [No Abstract] [Full Text] [Related]
4. Canadian media company demands right to publish direct to consumer drug advertising. Moynihan R BMJ; 2009 May; 338():b1912. PubMed ID: 19429658 [No Abstract] [Full Text] [Related]
9. Should medical journals carry drug advertising? Yes. Smith R BMJ; 2007 Jul; 335(7610):74. PubMed ID: 17626959 [TBL] [Abstract][Full Text] [Related]
10. The role of direct-to-consumer advertising. Navarro RP Manag Care Interface; 1998 Nov; 11(11):79-80, 82. PubMed ID: 10187419 [No Abstract] [Full Text] [Related]
11. Should medical journals carry drug advertising? No. Williams G BMJ; 2007 Jul; 335(7610):75. PubMed ID: 17626960 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical manufacturers likely to be challenged by regulatory agencies over assertions of deceptive advertising. Fine A Exec Solut Healthc Manag; 1999 Jun; 2(6):2-3. PubMed ID: 10538255 [No Abstract] [Full Text] [Related]
13. The pharmaceutical industry--to whom is it accountable? Jacobs C N Engl J Med; 2000 Nov; 343(19):1416-7; discussion 1417. PubMed ID: 11183878 [No Abstract] [Full Text] [Related]
14. Drug firms back-pedal on direct advertising. Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811 [No Abstract] [Full Text] [Related]
16. Turning point or tipping point: new FDA draft guidances and the future of DTC advertising. Pitts PJ Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-259-61. PubMed ID: 15452001 [TBL] [Abstract][Full Text] [Related]
17. A bitter pill for plaintiffs: obstacles to market theories of causation in prescription drug consumer fraud cases. Arden JD; Brensilver PC Food Drug Law J; 2006; 61(3):539-46. PubMed ID: 17001790 [No Abstract] [Full Text] [Related]
18. The development of direct-to-consumer prescription drug advertising regulation. Palumbo FB; Mullins CD Food Drug Law J; 2002; 57(3):423-43. PubMed ID: 12703509 [No Abstract] [Full Text] [Related]
20. The great debate over drug ads. Atkinson H Health News; 1999 Jun; 5(8):4. PubMed ID: 10397029 [No Abstract] [Full Text] [Related] [Next] [New Search]